These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1789189)

  • 1. Uridine fluxes in healthy proliferating T-lymphocytes, MOLT-3 T-ALL cell-line cells and differentiated MOLT-3 cells.
    van den Berg AA; van Lenthe H; de Korte D; Roos D; van Gennip AH
    Adv Exp Med Biol; 1991; 309A():117-20. PubMed ID: 1789189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for transformation-related increase in CTP synthetase activity in situ in human lymphoblastic leukemia.
    van den Berg AA; van Lenthe H; Busch S; de Korte D; Roos D; van Kuilenburg AB; van Gennip AH
    Eur J Biochem; 1993 Aug; 216(1):161-7. PubMed ID: 8365402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The roles of uridine-cytidine kinase and CTP synthetase in the synthesis of CTP in malignant human T-lymphocytic cells.
    van den Berg AA; van Lenthe H; Busch S; de Korte D; van Kuilenburg AB; van Gennip AH
    Leukemia; 1994 Aug; 8(8):1375-8. PubMed ID: 8057676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The roles of uridine-cytidine kinase and CTP synthetase in the synthesis of CTP in malignant human T-lymphocytic cells.
    van den Berg AA; van Lenthe H; van Kuilenburg AB; van Gennip AH
    Adv Exp Med Biol; 1994; 370():261-4. PubMed ID: 7660903
    [No Abstract]   [Full Text] [Related]  

  • 5. In situ regulation of mammalian CTP synthetase by allosteric inhibition.
    Aronow B; Ullman B
    J Biol Chem; 1987 Apr; 262(11):5106-12. PubMed ID: 2435724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytidine triphosphate (CTP) synthetase activity during cell cycle progression in normal and malignant T-lymphocytic cells.
    van den Berg AA; van Lenthe H; Kipp JB; de Korte D; van Kuilenburg AB; van Gennip AH
    Eur J Cancer; 1995; 31A(1):108-12. PubMed ID: 7695960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of resistance to cyclopentenyl cytosine (CPE-C) in Molt-4 lymphoblasts.
    Blaney SM; Grem JL; Balis FM; Cole DE; Adamson PC; Poplack DG
    Biochem Pharmacol; 1993 Apr; 45(7):1493-501. PubMed ID: 8471071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Incorporation of uridine into RNA, nucleic acid content and UTP content at functional different lymphocyte subpopulations of the human tonsil (author's transl)].
    Siegel G
    Allerg Immunol (Leipz); 1980; 26(3):253-9. PubMed ID: 6162375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of ribonucleotide pool specific activities by an in vivo method: comparison with an in vitro method.
    Falkenthal S; Lengyel JA
    Biochemistry; 1981 Jan; 20(2):312-9. PubMed ID: 6162483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular pharmacology of cyclopentenyl cytosine in Molt-4 lymphoblasts.
    Ford H; Cooney DA; Ahluwalia GS; Hao Z; Rommel ME; Hicks L; Dobyns KA; Tomaszewski JE; Johns DG
    Cancer Res; 1991 Jul; 51(14):3733-40. PubMed ID: 1712247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A77 1726 induces differentiation of human myeloid leukemia K562 cells by depletion of intracellular CTP pools.
    Huang M; Wang Y; Collins M; Mitchell BS; Graves LM
    Mol Pharmacol; 2002 Sep; 62(3):463-72. PubMed ID: 12181422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the incorporation of precursors into purine and pyrimidine nucleotides via 'de novo' and 'salvage' pathways in normal lymphocytes and lymphoblastic cell-line cells.
    Marijnen YM; de Korte D; Haverkort WA; den Breejen EJ; van Gennip AH; Roos D
    Biochim Biophys Acta; 1989 Jul; 1012(2):148-55. PubMed ID: 2787169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of the pyrimidine metabolism in pheochromocytoma PC-12 cells.
    Slingerland RJ; Van Gennip AH; Bodlaender JM; Voûte PA; Van Kuilenburg AB
    Eur J Biochem; 1995 Oct; 233(2):538-43. PubMed ID: 7588799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of temperature-sensitive cytidine triphosphate synthase mutations in bacteria by high-performance liquid chromatography.
    Bailey AJ; Dutta PK; Shanley MS; O'Donovan GA
    J Chromatogr; 1990 Jul; 512():403-7. PubMed ID: 2229235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of human malignant T-lymphoblastic cell lines MOLT-3 and jurkat by 12-O-tetradecanoylphorbol-13-acetate: biochemical, physical, and morphological characterization.
    Nagasawa K; Howatson A; Mak TW
    J Cell Physiol; 1981 Oct; 109(1):181-92. PubMed ID: 6976970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of pyrimidine nucleotides in the heart: uridine and cytidine kinase activity.
    Lortet S; Aussedat J; Rossi A
    Arch Int Physiol Biochim; 1987 Nov; 95(4):289-98. PubMed ID: 2453171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Separate pyrimidine-nucleotide pools for messenger-RNA and ribosomal-RNA synthesis in HeLa S3 cells.
    Wiegers U; Kramer G; Klapproth K; Hilz H
    Eur J Biochem; 1976 May; 64(2):535-40. PubMed ID: 1278172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substrate specificity of CTP-synthetase from E. coli.
    Scheit KH; Linke HJ
    Nucleic Acids Symp Ser; 1981; (9):229-33. PubMed ID: 7029474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of D-glucosamine and 6-azauridine on nucleotide contents, 5-fluorouridine uptake, and cytotoxicity in TA3 mammary tumor cells.
    Holstege A; Keppler D
    J Natl Cancer Inst; 1986 Mar; 76(3):485-92. PubMed ID: 2419623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro inhibition of cytidine triphosphate synthetase activity by cyclopentenyl cytosine in paediatric acute lymphocytic leukaemia.
    Verschuur AC; Van Gennip AH; Leen R; Meinsma R; Voute PA; van Kuilenburg AB
    Br J Haematol; 2000 Jul; 110(1):161-9. PubMed ID: 10930994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.